{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:51:39Z","timestamp":1791510699824,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2025ZDXM029"],"award-info":[{"award-number":["2025ZDXM029"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2025NSCO-GPX0009"],"award-info":[{"award-number":["CSTB2025NSCO-GPX0009"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0694"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0694"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.lfs.2026.124710","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:15:16Z","timestamp":1790205316000},"page":"124710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A ketogenic enzyme HMGCS2 drives malignant progression in HER2-negative breast cancer via RAB23-mediated \u03b2-catenin\/TCF signaling and mediates Apatinib resistance"],"prefix":"10.1016","volume":"405","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.lfs.2026.124710_bb0005","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/cncr.32057","article-title":"Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): a randomized, controlled, multicenter trial","volume":"125","author":"Yu","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bulcan.2024.09.002","article-title":"Triple negative breast cancer: current status and perspectives","volume":"112","author":"Le Du","year":"2025","journal-title":"Bull. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2026.124710_bb0015","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","article-title":"Triple-negative breast cancer--current status and future directions","volume":"20","author":"Gluz","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lfs.2026.124710_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.828438","article-title":"New advances in targeted therapy of HER2-negative breast cancer","volume":"12","author":"An","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2026.124710_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102569","article-title":"Novel endocrine therapies: what is next in estrogen receptor positive, HER2 negative breast cancer?","volume":"117","author":"Corti","year":"2023","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2026.124710_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-024-07415-6","article-title":"First- vs second-line CDK 4\/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting","volume":"208","author":"Kimmick","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lfs.2026.124710_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.lfs.2026.124710_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071183","article-title":"Advanced and metastatic triple negative breast cancer-potential new treatment","volume":"17","author":"Pajewska","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.lfs.2026.124710_bb0045","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative breast cancer therapy: current and future perspectives","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-022-00462-6","article-title":"Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first\/second-line treatment: the NAN trial","volume":"8","author":"Li","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2026.124710_bb0055","doi-asserted-by":"crossref","first-page":"875","DOI":"10.20892\/j.issn.2095-3941.2020.0418","article-title":"Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA","volume":"18","author":"Zhu","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"36","key":"10.1016\/j.lfs.2026.124710_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012222","article-title":"Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: a retrospective study","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lfs.2026.124710_bb0065","article-title":"Real-world data on apatinib efficacy - results of a retrospective study in metastatic breast cancer patients pretreated with multiline treatment","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124710_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317711033","article-title":"Apatinib for metastatic breast cancer in non-clinical trial setting: satisfying efficacy regardless of previous anti-angiogenic treatment","volume":"39","author":"Lin","year":"2017","journal-title":"Tumour Biol."},{"issue":"10","key":"10.1016\/j.lfs.2026.124710_bb0075","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2174\/0115680096303785240822155217","article-title":"A phase II clinical study on apatinib plus vinorelbine in refractory HER2-negative breast cancer and its metabolic implications of drug resistance","volume":"24","author":"Wu","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.lfs.2026.124710_bb0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.lfs.2026.124710_bb0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-020-03431-w","article-title":"The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma","volume":"147","author":"Vallejo","year":"2020","journal-title":"J. Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124710_bb0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jmb.2010.03.034","article-title":"Crystal structures of human HMG-CoA synthase isoforms provide insights into inherited ketogenesis disorders and inhibitor design","volume":"398","author":"Shafqat","year":"2010","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41392-021-00570-y","article-title":"Fructose drives mitochondrial metabolic reprogramming in podocytes via Hmgcs2-stimulated fatty acid degradation","volume":"6","author":"Fang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.lfs.2026.124710_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194123","article-title":"Morphological adaptation in the jejunal mucosa after iso-caloric high-fat versus high-carbohydrate diets in healthy volunteers: data from a randomized crossover study","volume":"14","author":"Casselbrant","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.lfs.2026.124710_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091961","article-title":"A fatty diet induces a jejunal ketogenesis which inhibits local SGLT1-based glucose transport via an acetylation mechanism-results from a randomized cross-over study between iso-caloric high-fat versus high-carbohydrate diets in healthy volunteers","volume":"14","author":"Elebring","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.lfs.2026.124710_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/abbi.1995.1178","article-title":"Molecular cloning and tissue expression of human mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase","volume":"317","author":"Mascaro","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.lfs.2026.124710_bb0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.mehy.2015.08.002","article-title":"Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1","volume":"85","author":"McCarty","year":"2015","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.lfs.2026.124710_bb0120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbrc.2017.03.069","article-title":"HMGCS2 promotes autophagic degradation of the amyloid-beta precursor protein through ketone body-mediated mechanisms","volume":"486","author":"Hu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.lfs.2026.124710_bb0125","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/iub.2337","article-title":"Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme a synthase 2 expression","volume":"72","author":"Wang","year":"2020","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1249\/MSS.0000000000002453","article-title":"Exercise training reverses lipotoxicity-induced cardiomyopathy by inhibiting HMGCS2","volume":"53","author":"Li","year":"2021","journal-title":"Med. Sci. Sports Exerc."},{"issue":"12","key":"10.1016\/j.lfs.2026.124710_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121876","article-title":"HMGCS2 mediates ketone production and regulates the proliferation and metastasis of hepatocellular carcinoma","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2026.124710_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153622","article-title":"Epigenetic inactivation of hydroxymethylglutaryl CoA synthase reduces ketogenesis and facilitates tumor cell motility in clear cell renal carcinoma","volume":"227","author":"Han","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.lfs.2026.124710_bb0145","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2147\/OTT.S132543","article-title":"Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients","volume":"10","author":"Tang","year":"2017","journal-title":"Onco. Targets Ther."},{"issue":"14","key":"10.1016\/j.lfs.2026.124710_bb0150","doi-asserted-by":"crossref","first-page":"22460","DOI":"10.18632\/oncotarget.13006","article-title":"HMGCS2 enhances invasion and metastasis via direct interaction with PPARalpha to activate Src signaling in colorectal cancer and oral cancer","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.lfs.2026.124710_bb0155","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1074\/mcp.M112.023887","article-title":"Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression","volume":"12","author":"Saraon","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.lfs.2026.124710_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8348967","article-title":"Potential role of HMGCS2 in tumor angiogenesis in colorectal cancer and its potential use as a diagnostic marker","volume":"2019","author":"Zou","year":"2019","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12964-019-0505-5","article-title":"Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis","volume":"18","author":"Neuwirt","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.lfs.2026.124710_bb0170","article-title":"A coagulation-related gene-based prognostic model for invasive ductal carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.lfs.2026.124710_bb0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1158\/1940-6207.CAPR-12-0304","article-title":"Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer","volume":"6","author":"Wang","year":"2013","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"11","key":"10.1016\/j.lfs.2026.124710_bb0180","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/ijc.30680","article-title":"Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer","volume":"140","author":"Wang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2026.124710_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101676","article-title":"G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells","volume":"33","author":"Corbet","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.lfs.2026.124710_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121827","article-title":"Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death","volume":"328","author":"Hwang","year":"2023","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.lfs.2026.124710_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112024","article-title":"FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast","volume":"9","author":"Gromov","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lfs.2026.124710_bb0200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/1541-7786.MCR-05-0267","article-title":"Ketogenic HMGCS2 is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer","volume":"4","author":"Camarero","year":"2006","journal-title":"Mol. Cancer Res."},{"issue":"9","key":"10.1016\/j.lfs.2026.124710_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091106","article-title":"Regulation of ketogenic enzyme HMGCS2 by Wnt\/beta-catenin\/PPARgamma pathway in intestinal cells","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gene.2016.09.028","article-title":"RAB23, regulated by miR-92b, promotes the progression of esophageal squamous cell carcinoma","volume":"595","author":"Cheng","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2026.124710_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101055","article-title":"Lipids in the tumor microenvironment: from cancer progression to treatment","volume":"80","author":"Corn","year":"2020","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.lfs.2026.124710_bb0220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11684-022-0943-0","article-title":"Sodium butyrate activates HMGCS2 to promote ketone body production through SIRT5-mediated desuccinylation","volume":"17","author":"Xu","year":"2023","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.lfs.2026.124710_bb0225","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2019.07.048","article-title":"Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet","volume":"178","author":"Cheng","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13046-024-03095-8","article-title":"A novel lncRNA LOC101928222 promotes colorectal cancer angiogenesis by stabilizing HMGCS2 mRNA and increasing cholesterol synthesis","volume":"43","author":"Chang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0235","article-title":"Downregulation of Rab23 inhibits hepatocellular carcinoma by repressing SHH signaling pathway","volume":"7","author":"Liu","year":"2024","journal-title":"Cancer rep. (Hoboken)"},{"issue":"6","key":"10.1016\/j.lfs.2026.124710_bb0240","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jnr.20788","article-title":"Open brain gene product Rab23: expression pattern in the adult mouse brain and functional characterization","volume":"83","author":"Guo","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.lfs.2026.124710_bb0245","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3892\/or.2015.4152","article-title":"Effect of Rab23 on the proliferation and apoptosis in breast cancer","volume":"34","author":"Liu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2026.124710_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12253-018-0463-z","article-title":"Rab23 promotes hepatocellular carcinoma cell migration via Rac1\/TGF-beta signaling","volume":"26","author":"Zhang","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2026.124710_bb0255","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8143","article-title":"MiR-367-3p downregulates Rab23 expression and inhibits hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells","volume":"46","author":"Du","year":"2021","journal-title":"Oncol. Rep."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526005199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526005199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:29:03Z","timestamp":1791509343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526005199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"alternative-id":["S0024320526005199"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124710","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A ketogenic enzyme HMGCS2 drives malignant progression in HER2-negative breast cancer via RAB23-mediated \u03b2-catenin\/TCF signaling and mediates Apatinib resistance","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"124710"}}